This has been observed previously in genetically engineered mammary tumor models, where in c-Myc-driven tumors there was no association between [18F]FDG uptake and GLUT1 expression or with tumor growth rate or cell proliferation, although there was a correlation with HKII expression [37]. This evidence concerns the gene MYC and breast cancer.